Top Markets
#1 Nesa Nesa +337.52%
#2 EXOD EXOD +22.78%
#3 MetaDAO MetaDAO +18.79%
#4 Status Status +9.46%
#5 Venom Venom +8.67%
#6 PondCoin PondCoin +7.93%
#7 Wrapped NXM Wrapped NXM +7.88%
#8 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +6.93%
#9 Kinesis Silver Kinesis Silver +6.91%
#10 Tornado Cash Tornado Cash +5.66%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

ORKA
Rank in Stocks #3143
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Share Price
$100.91
Last synced: 2026-08-25
Market Cap
$6.09B
Change (1 day)
-1.47%
Change (1 year)
581.36%
Country
US
Trade Oruka Therapeutics, Inc. (ORKA)

Category

Healthcare
Earnings for Oruka Therapeutics, Inc. (ORKA)
Earnings in 2026 TTM: 0
According to Oruka Therapeutics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Oruka Therapeutics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH